Publication | Closed Access

Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up

Chronic PhaseChromatinHematological MalignancyMedicineHematologyPathologyNilotinib Vs ImatinibEnestnd 3-Year Follow-upOncologyCancer ResearchMyeloid Neoplasia